Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies

TDP-43 Proteinopathies trial results

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Novartis USA East Hanover, New Jersey, United States
  • Novartis Belgium Vilvoorde, Belgium
  • Novartis CANADA Dorval, Quebec, Canada
  • Novartis France Rueil-Malmaison, France
Conditions
Alzheimer Disease, Alzheimer's Disease, Arterial Occlusive Diseases, +31 more
Locations
  • Hôpital Privé Les Magnolias Ballainvilliers, France
  • Cabinet Médical Bergerac, France
  • Centre Médical Dijon, France
  • Cabinet Médical La Seyne-sur-Mer, France
View all 21 locations
Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +9 more
Locations
  • Phoenix Neurological Associates Phoenix, Arizona, United States
  • UCLA Los Angeles, California, United States
  • University of California Irvine Orange, California, United States
  • California Pacific Medical Center San Francisco, California, United States
View all 19 locations